BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  On the Road to ASCO: Preview Some Key Presentations

  BioSpace continues to take a look at some of the data that will be shared at the 2021 ASCO meeting. Here are some of them.

  June 2, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Global Roundup: BioVersys Secures CARB-X Funds for Multidrug Resistant Research

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  June 2, 2021

   · 

  5 min read

   · 

  Alex Keown
• 

  15 Good Qualities of a Person That Make Them a Great Employee

  Here we will answer the two important questions “what are the best qualities of a person to ace at the office?” and “what do companies normally look for in a person?”

  June 2, 2021

   · 

  5 min read

   · 

  Lorenzo Soliman
• 

  Drug Development

  Calliditas is Getting to the Heart of Berger’s Disease

  Calliditas is developing Nefecon, a down regulator of IgA1 and proprietary, novel oral formulation of budesonide – a potent and established immunosuppressant – for the treatment of IgAN.

  June 2, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Pharm Country

  Iveric Bio Expands into Gene Therapy for Untreated Retinal Diseases

  When Iveric Bio established its gene therapy advisory committee recently, the move signaled the opening of a second front in its mission to treat retinal diseases for which there are no treatments.

  June 2, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Genetown

  New Study on Cellular Immunity Offers Insight for Future COVID-19 Vaccine Design

  Repertoire believes the findings, which provide an updated understanding of viral antigen presentation and epitope selection, may assist in vaccine development for COVID-19.

  June 2, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  FDA

  First Six-In-One Pediatric Combination Vaccine VAXELIS Now Available in the United States

  The new vaccination, dubbed VAXELIS, is indicated for active immunization to help prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.

  June 2, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  Researchers Scramble to Make COVID-19 Manageable with Antivirals

  Researchers at multiple companies and institutes are doggedly pursuing clinical programs so the virus can become little more than a hindrance in the future.

  June 2, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  MorphoSys Pharma’s Double Deal: Buys Constellation and Enters Partnership with Royalty Pharma

  MorphoSys Pharma is acquiring Constellation Pharmaceuticals for about $1.7 billion. Here’s everything you need to know about this billion dollars deal.

  June 2, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Novartis Blockbuster Cosentyx Gets FDA Nod in Pediatric Plaque Psoriasis

  The new approval for Cosentyx marks the first for a pediatric patient population in the U.S. Here’s everything you need to know about this new drug from Novartis.

  June 2, 2021

   · 

  3 min read

   · 

  Brandon May